Literature DB >> 13344447

The anticancerous action of 6-azauracil (3, 5-dioxo-2, 3, 4, 5-tetrahydro-1, 2, 4-triazine).

F SORM, A JAKUBOVIC, L SLECHTA.   

Abstract

Entities:  

Keywords:  NEOPLASMS/experimental; URACIL/derivatives

Mesh:

Substances:

Year:  1956        PMID: 13344447     DOI: 10.1007/bf02157344

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  2 in total

1.  Effect of various compounds on the Ehrlich ascites carcinoma.

Authors:  K SUGIURA
Journal:  Cancer Res       Date:  1953-06       Impact factor: 12.701

2.  Studies in 2-acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma.

Authors:  R J RUTMAN; A CANTAROW; K E PASCHKIS
Journal:  Cancer Res       Date:  1954-02       Impact factor: 12.701

  2 in total
  5 in total

1.  The inhibitory effect of 6-azauracil riboside on the multiplication of vaccinia virus.

Authors:  B RADA; D BLASKOVIC; F SORM; J SKODA
Journal:  Experientia       Date:  1960-11-15

2.  The biosynthesis of 6-azauracil riboside by Escherichia coli growing in the presence of 6-azauracil.

Authors:  J SKODA; V F HESS; F SORM
Journal:  Experientia       Date:  1957-04-15

3.  The anti-tumour activity of 6-azauracil riboside.

Authors:  F SORM; H KEILOVA
Journal:  Experientia       Date:  1958-06-15

4.  Six-Azauracil Treatment of Experimental Avian Lymphomatosis.

Authors:  V L Sanger
Journal:  Can J Comp Med Vet Sci       Date:  1962-01

5.  Studies on the carcinostatic activity in mice of 6-azauracil riboside (azauridine), in comparison with that of 6-azauracil.

Authors:  J J JAFFE; R E HANDSCHUMACHER; A D WELCH
Journal:  Yale J Biol Med       Date:  1957-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.